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Cardiac tissue regeneration is guided by stem cells and their microenvironment. It has been recently described that both cardiac
stem/primitive cells and extracellular matrix (ECM) change in pathological conditions. This study describes the method for
the production of ECM typical of adult human heart in the normal and pathological conditions (ischemic heart disease) and
highlights the potential use of cardiac fibroblast-derived ECM for in vitro studies of the interactions between ECM components
and cardiac primitive cells responsible for tissue regeneration. Fibroblasts isolated from adult human normal and pathological heart
with ischemic cardiomyopathy were cultured to obtain extracellular matrix (biomatrix), composed of typical extracellular matrix
proteins, such as collagen and fibronectin, and matricellular proteins, laminin, and tenascin. After decellularization, this substrate
was used to assess biological properties of cardiac primitive cells: proliferation and migration were stimulated by biomatrix from
normal heart, while both types of biomatrix protected cardiac primitive cells from apoptosis. Our model can be used for studies of
cell-matrix interactions and help to determine the biochemical cues that regulate cardiac primitive cell biological properties and
guide cardiac tissue regeneration.
1. Introduction
Advances in stem cell biology and recent reports of stem
cells and progenitors cells residing in the adult human heart
gave origin to cardiovascular regenerative medicine, and this
approach to the heart failure treatment immediately captured
the attention of clinicians [1]. Numerous preclinical studies
and clinical trials have aimed at the use of stem cells in
the therapy of infrcted heart or ischemic cardiopathy [2],
evolving from cell therapy to refined bioengineering. In the
era of tissue engineering, there is an ongoing interest in
the development of biomimetic materials that would be able
to elicit specific cellular responses and direct tissue forma-
tion based on either intrinsic tissue regeneration capacity
(provided by resident stem cells) or scaffold-incorporated or
scaffold-seeded stem cells [3]. Several such approaches to
cardiac tissue regeneration have been developed and are still
under investigation (reviewed in [4]).
All cells exist in vivo in a specialized environment
in which their survival and function are assured, while
their biological activity is controlled. Extracellular matrix
(ECM), with growth factors stored within it, contributes
to this microenvironment. While the expression of some
ECM components, among which matricellular proteins, is
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typical of tissue development and organogenesis [5, 6],
a number of cardiac diseases, includingmyocardial ischemia,
are associated with qualitative and quantitative alterations in
ECM proteins [7]. Cardiac resident or homing stem cells,
as well as cells injected in or applied onto myocardium
in cell-populated scaffolds interact with ECM components
and respond to the local tissue conditions accordingly [8].
Therefore it seems reasonable that the role of ECM and,
even more importantly, the effects of the modifications of its
composition ongoing in pathological conditions should be
studied and taken into consideration when planning the use
of cardiac primitive cell-mediated tissue regeneration.
This study describes the method for the in vitro produc-
tion of ECM typical of adult human heart in the normal and
pathological conditions (ischemic heart disease) and high-
lights the potential use of cardiac fibroblast-derived ECM for
in vitro studies of the interactions between ECM components
and cardiac primitive cells responsible for tissue regeneration.
2. Materials and Methods
2.1. Cardiac Tissue Samples. Cardiac tissue samples were
obtained from the left atrium of hearts from patients with
end-stage heart failure due to ischemic heart disease, under-
going heart transplantation (𝑛 = 9, mean age 55.8 ± 3.1 years,
7 males, 2 females, mean ejection fraction 25 ± 1%). Samples
of atrial appendages from normal hearts (𝑛 = 9, mean age
50.4 ± 4.1 years, 6 males, 3 females) were collected from the
donor heart waste fragments, that is, tissue trimmed off from
the heart while adjusting atrium size and form at the time
of organ transplantation. Specimens were collected without
patient identifiers following protocols approved by Monaldi
Hospital and in conformity with the principles outlined in the
Declaration of Helsinki.
2.2. Isolation of Fibroblasts and Cardiac Primitive Cells. Car-
diac tissue samples were dissected, minced, and enzymati-
cally disaggregated by incubation in 0.25% trypsin (Sigma-
Aldrich, St. Louis, MO, USA) and 0.1% (w/v) collagenase
II (both from Sigma-Aldrich, St. Louis, MO, USA) for 30
minutes at 37∘C. The digestion was stopped by adding
double volume of HBSS supplemented with 10% FBS. This
preparation was further disaggregated by pipetting and tissue
debris and cardiomyocytes were removed by sequential cen-
trifugation at 100 g for 2 minutes, passage through 20 𝜇m
sieve, and centrifugation at 400 g for 5 minutes.
Obtained cell population was used for isolation of
fibroblasts and cardiac primitive cells by immunomagnetic
cell sorting based on Miltenyi Biotec (Bergisch Gladbach,
Germany) protocol. Fibroblasts were purified by positive
selectionwith antifibroblastMicroBeads andpassage through
MS columns placed in magnetic field, followed by incubation
of the collected negative fraction with anti-human-CD117
MicroBeads and positive selection of CD117-positive cardiac
primitive cells.
2.3. Extracellular Matrix Deposition and Decellularization In
Vitro. The previously published protocols [9, 10] have been
modified and optimized for the culture of cardiac primi-
tive cells from adult human heart. Cardiac fibroblasts were
seeded on gelatin-coated plates in DMEM supplemented
with 10% fetal bovine serum and cultured in confluent state
(15 × 103 cells per cm2) for up to 21 days, allowing for
extracellularmatrix (ECM)deposition.Then, fibroblastswere
removed by incubation with a solution of 0.25% Triton X-
100 and 10mM NH
4
OH in PBS prewarmed to 37∘C. The
decellularization process was observed at an inverted phase
contrast microscope (Olympus Italia, Segrate, Italy). After
1-2 minutes, when cells were no longer discernible, the
decellularization solution was diluted and removed, followed
by gentle washing of culture plates with PBS. Fibroblast-
derived ECM was photographed with a computer-assisted
digital camera connected to the microscope (Color View
IIIu, Soft Imaging System, Muenster, Germany) and stored at
+4∘C.
2.3.1. Immunofluorescence. Both fibroblasts during ECM se-
cretion and fibroblast-derived ECM after decellularization
(biomatrix) were fixed in 4% paraformaldehyde for 20 min-
utes at room temperature. After blocking with 10% don-
key serum, plates were incubated with primary antibody
against fibronectin (rabbit polyclonal anti-human, Sigma-
Aldrich), collagen IV (mouse monoclonal anti-human,
Sigma-Aldrich), tenascin-C (rabbit polyclonal anti-human,
Santa Cruz Biotechnology, Dallas, TX, USA), or laminin
(mouse monoclonal anti-human, Sigma-Aldrich) and spe-
cific secondary antibodies conjugated with fluorescein or
rhodamine (Jackson ImmunoResearch Europe, Newmarket,
UK); F-actin was stained with rhodamine phalloidin (Sigma-
Aldrich). Nuclei were counterstained with DAPI (Merck
Millipore, Billerica,MA,USA), and the stained area of culture
dish was mounted in Vectashield (Vector Labs, Burlingame,
CA, USA). Microscopic analysis was performed with a Leica
DMLB microscope equipped with epifluorescence EL6000
system (LeicaMicrosystems). Pictures were takenwith digital
camera connected to the microscope (Leica DFC345FX) and
then merged with the software Leica Application Suite 3.6.
2.3.2. Electrophoresis and Immunoblotting. Control plates
were used to evaluate the number of fibroblastswhen cultured
in confluent state: no statistically significant difference in
cell number was observed between plates with normal and
pathological fibroblasts. Protein extracts were prepared from
biomatrix secreted by normal (Bm-N) and pathological (Bm-
P) heart-derived fibroblasts. Lysates containing 30 𝜇g of
proteins were size fractionated by electrophoresis on 8% SDS-
polyacrylamide gel and transferred onto a PVDF membrane
(Merck Millipore). Molecular weight markers were loaded
onto each gel as a weight indicator. The membranes were
blocked and then incubated with one of the following anti-
bodies: tenascin-X, laminin 𝛼1, laminin 𝛼2, fibronectin, and
collagen I, followed by horseradish peroxidase-labelled sec-
ondary IgG (all from Santa Cruz Biotechnology). Antibody
binding was visualized by chemiluminescence (Amersham
Biosciences, Piscataway, NJ, USA) and autoradiography
(Eastman Kodak Company, Rochester, NY, USA).
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2.4. Cardiac Primitive Cell Culture. Pathological heart-de-
rived CD117-positive cells were plated on biomatrix-covered
culture dishes at a density of 8.5 × 103 cells per cm2 in
Dulbecco’s modified Eagle’s medium-Ham’s F-12 medium
(Sigma-Aldrich) supplemented with 10% fetal calf serum
(Sigma-Aldrich), basic fibroblast growth factor (Peprotech,
Rocky Hill, NJ, USA), glutathione (Sigma-Aldrich), peni-
cillin, and streptomycin (Life Technologies, Paisley, UK). For
evaluation of their proliferation, apoptosis, and migration,
cells cultured on surface treated with bovine serum albumin
(CTR), biomatrix secreted by normal (Bm-N), and patholog-
ical (Bm-P) heart-derived fibroblasts were starved in serum-
free medium for 24 hours. All in vitro experiments were
repeated a minimum of three times, in triplicate.
2.4.1. Proliferation. For evaluation of proliferation, quies-
cent cells were incubated with the complete medium for
24 hours, and 5-bromo-2󸀠-deoxyuridine (BrdU) was added
(1 : 1.000) for 1 hour before cell fixation. Incorporation of
BrdU was evaluated by immunofluorescence with the use
of BrdU Labeling and Detection Kit (Roche Diagnostics,
Basel, Switzerland), according to themanufacturer’s protocol.
Nuclei were counterstained with DAPI (Merck Millipore),
and the stained area of culture dish was mounted in Vec-
tashield (Vector Labs). Microscopic analysis was performed
with a Leica DMLB microscope equipped with epifluores-
cence EL6000 system (Leica Microsystems).
2.4.2. Apoptosis. For evaluation of apoptosis, cells were incu-
bated with 200𝜇M hydrogen peroxide in the complete
medium for 24 hours and fixed in 1% paraformaldehyde.
The fragmentation of DNA was detected using the ApopTag
Plus Fluorescein In Situ Apoptosis Detection Kit (Merck
Millipore) based on terminal transferase dUTP nick end
labeling, according to the manufacturer’s protocol. Nuclei
were counterstained with DAPI (Merck Millipore), and the
stained area of culture dish was mounted in Vectashield
(Vector Labs). Microscopic analysis was performed with
a Leica DMLB microscope equipped with epifluorescence
EL6000 system (Leica Microsystems).
2.4.3. Migration. For the evaluation of migration of cardiac
primitive cells in the presence of biomatrix, cells were grown
to confluence, and a thin scratch was introduced on culture
plates with a pipette tip, producing a cell-free zone [11]. The
plates were observed at an inverted phase contrast micro-
scope (Olympus Italia) and photographed with computer-
assisted digital camera (Soft Imaging System) at five distinct
points, previously marked along the scratch on every culture
plate, at various time points. Cell migration was quantified by
measuring the width of the cell-free zone (distance between
the edges of the scratched cell monolayer) at every time point
with CellA Imaging Software for Life Sciences Microscopy
(Soft Imaging System).
2.5. Statistical Analysis. All numerical data are presented as
mean ± SEM. Statistical differences between groups were
Figure 1: Biomatrix synthesis. Fibroblasts isolated from samples
of adult human heart were cultured in confluent state allowing
for ECM deposition in vitro. Representative image obtained by
immunofluorescent labelling of actin filaments (red), cell nuclei
(blue), and fibronectin (green).
evaluated with Student’s two-tailed unpaired t-test; 𝑃 < 0.05
was considered significant.
3. Results and Discussion
3.1. Biomatrix Production and Characterization. Fibroblasts
isolated from samples of adult human heart were cultured
in confluent state allowing for ECM deposition in vitro
(Figure 1). Incubation with basic solution of Triton X-100
induced membrane permeabilization and cell lysis, resulting
in the removal of fibroblasts. Decellularized matrix adhered
to culture plate; its presence was observed at phase contrast
microscope (Figure 2(a)), while its composition was revealed
by indirect immunofluorescent staining of representative
extracellular matrix proteins and glycoproteins (Figure 2(b)):
fibronectin, collagen, laminin, and tenascin.
An organized ECM is necessary for the arrangement
of cells and thus for the maintenance of structure in any
given tissue; this intricate interlocking mesh of fibrillar
and nonfibrillar proteins and glycosaminoglycans also deter-
mines tissue biomechanical properties. Numerous cell types
are able to synthesise and secrete ECM components, and
their activity is regulated and changes in response to var-
ious stimuli, such as inflammation, biomechanical stress,
and tumorigenesis [12]. Similarly, already deposited ECM
proteins are targeted by specific enzymes,metalloproteinases,
that are responsible for the continuous remodeling of ECM
and allow cell movement and size adaptation. In any necrotic
tissue, fibronectin and collagen deposition is responsible for
scar formation, which preserves wall integrity and thickness.
Life-threatening pathologies ensue when ECM remodelling
becomes exacerbated by chronic stimuli. Also in the ischemic
heart disease or cardiac pressure overload, cardiomyocyte
hypertrophy is accompanied by interstitial fibrosis, while the
necrotic tissue is substituted by a scar [13]. However, in the
chronic conditions such ECM remodelling increases wall
stiffness, contributes to cardiomyocyte slippage, and worsens
the contractile properties of the myocardium [14]. On these
bases, it is becoming increasingly evident that secretory
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Figure 2: Decellularized biomatrix. (a) After nonenzymatic removal of fibroblasts, ECM was observed at phase contrast microscope
(A). Its composition was revealed by indirect immunofluorescent staining of representative extracellular matrix proteins (B) collagen IV
(red), laminin (green), fibronectin (blue), and tenascin-C (yellow). (b) Electrophoresis of biomatrix, followed by immunoblotting, revealed
semiquantitative differences in biomatrix composition.
activity of fibroblasts, which exceed in number any other cell
type in the myocardium, influences myocardial function: it
is determinant in normal, but detrimental in pathological
conditions.
The synthetic and secretory activity of cardiac fibroblasts
isolated from normal or pathological adult human heart
can be studied in our model of fibroblast cell culture in
vitro. The soluble factors condition the medium used for
fibroblast maintenance, while the fibrillar and nonfibrillar
proteins are deposited as biomatrix on culture plates. Both
ECM components can be further analyzed by analytical
methods, and their biological function can be tested on
various cell types cultured in the presence of fibroblast-
conditioned medium or on decellularized biomatrix. The
choice of decellularization method is essential for ECM
preservation [15] and subsequent use of extracellular matrix
as a substrate for cell biology studies in vitro. Similarity in the
composition and biological properties of the decellularized
substrates to those of the native tissue is a prerequisite, as it
grants the preserved role in the remodelling of tissue struc-
ture and modulation of cell function. In fact, many protein
components of extracellular matrix react with each other
and with the specific membrane receptors based on their
secondary, tertiary, or quaternary structure. In our study,
decellularization with nondenaturing solution allowed the
preservation of protein structure. Further removal of cellular
debris was accomplished by gentle washing. If molecular
studies of cells cultured on naturally derived matrix are
programmed, biomatrix should be treated with endonuclease
before cell seeding.
3.2. Cardiac Primitive Cell Culture on Biomatrix. Recently,
ECM proteins with a role that goes beyond the structural and
mechanical support have been distinguished among other
ECM components and termed matricellular proteins [16].
This group encompasses proteins that modulate cell function
by interacting directly with cells or by modulating the
activity of soluble factors present in extracellular microenvi-
ronment, thus influencing cell migration, proliferation, and
differentiation [17]. Moreover, these proteins present unique
expression pattern, with high levels during organogenesis,
virtual absence in normal adult tissue, and reexpression in
response to injury and tissue regeneration. In the heart,
osteopontin, osteonectin, thrombospondins, tenascin, and
CCN family are the matricellular proteins identified so far
[18], but laminin-1 also fulfills the requirements [19]. Given
these properties, extracellular matrix, and matricellular pro-
teins in particular, can drive cardiac tissue regeneration,
described in adult human heart in infarction or pressure
overload [20]. Such regeneration depends on cardiac stem
cells and their progenies-cardiac primitive cells committed to
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Figure 3: Biological characteristics of cardiac primitive cells isolated from adult human heart with ischemic heart disease cultured in the
presence of ECM typical of normal and pathological adult human heart. Proliferation (a), apoptosis (b), and migration (c) were influenced
by the type of the substrate. Representative images of incorporated BrdU (for evaluation of proliferation), nick end-incorporated nucleotides
(for evaluation of apoptosis) immunofluorescent staining (scale bar corresponds to 50𝜇m), and scratch wound assay at baseline and after 6
hours (for evaluation of migration, scale bar corresponds to 100 𝜇m) are shown beside the corresponding graphs. CTR: cells grown on bovine
serum albumin; Bm-N: cells grown on biomatrix synthesised by fibroblasts from normal adult human hearts; Bm-P: cells grown on biomatrix
synthesised by fibroblasts from hearts with ischemic cardiopathy. ∗𝑃 < 0,05 versus CTR; #𝑃 < 0,05 versus Bm-N.
cardiomyocyte, endothelial, and smooth muscle cell lineage
[21].
The biomatrix, obtained in our study by culturing fibrob-
lasts derived from adult human heart, contained various
extracellular components, including laminin and tenascin
protein family. Consequently, we used this fibroblast derived-
ECM as a substrate for the culture of cardiac primitive
cells in vitro. Given the differences in biomatrix compo-
sition, revealed by western blotting (Figure 2), two types
of biomatrix—Bm-N, produced by fibroblasts isolated from
the fragments of adult human normal heart of donors died
for reasons other than cardiovascular disease, and Bm-P,
produced by fibroblasts isolated from the fragments of adult
human hearts of patients with end-stage heart failure due
to ischemic cardiopathy, undergoing heart transplantation—
were used in this part of the study, enabling us to test the
integrity and functionality of biomatrix and to compare the
effects of ECM typical of normal and pathological conditions
on cardiac primitive cell proliferation, apoptosis, and migra-
tion in vitro.
Proliferation of cardiac primitive cells (Figure 3(a)) on
Bm-P was 147% of control (𝑛 = 3, 𝑃 < 0.01) and 177%
of that in the presence of Bm-N (𝑛 = 3, 𝑃 < 0.01).
The presence of biomatrix protected cells from apoptosis
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(Figure 3(b)) provoked by oxidative stress (𝑛 = 6, 𝑃 < 0.01),
although no statistically significant advantage of specific
biomatrix type was evident. Migration of cardiac primitive
cells (Figure 3(c)) was the fastest on Bm-N; in the presence of
Bm-P, it was similar to that of control but significantly slower
when comparedwith the speed ofmigration on Bm-N (𝑛 = 9,
𝑃 < 0.05).
It is arguable that the differences in cardiac primitive
cell biological properties observed in the presence of dif-
ferent culture substrates (ECM deposited by normal and
pathological heart-derived fibroblasts) reflect the changes
in fibroblast synthesis and secretory activity, and thus in
biomatrix composition. Several authors, including our group,
have described the changes of cardiac stem/primitive cells
biological properties in pathological conditions or aging
[22, 23], but the contribution of microenvironment has not
been considered and sufficiently acknowledged due to the
lack of an appropriate model for cell-matrix interaction
studies. The molecular constituents of ECM play major role
in the responses of cells to their local microenvironment.
Both direct stimulation of the specific receptors by growth
factors stored in ECM and indirect activation by specific
integrin expression and clustering can transmit extracellular
biochemical inputs along the intracellular signaling pathways
that regulate cell proliferation, survival, and migration [24].
As a matter of fact, the expression of integrin subunits
in the same cardiac primitive cell population changes in
qualitative and quantitative manner depending on our cul-
ture substrate (Bm-N or Bm-P, data not shown). From the
above observations it follows that the composition of ECM
must be taken into consideration when planning cardiac
regeneration based on stem/primitive cell transplantation.
Tissue regeneration can be accomplished by cells able to
survive, proliferate, migrate, and differentiate in the host
environment. While the methods of genetic engineering of
stem cells and their application in human disease therapy
are still under investigation [25], the aforementioned cell
characteristics can be enhanced by cell-matrix interactions.
In mammals, nearly 300 proteins (among which colla-
gen subunits, proteoglycans, and glycoproteins) have been
identified as components of ECM [26]. So far, only few of
them have been recombinantly expressed or purified and are
available for the in vitro studies of their role in cell biology.
Considering the interactions among ECM constituents, the
possible influence on cardiac primitive cells is difficult to
predict. Hence, our model of ECM production by cardiac
fibroblasts and its use as a substrate for cardiac primitive
cell culture may fill this gap and improve the results of
cell transplantation. In the light of our ongoing study, the
modification of biomaterials with bioactive molecules [27,
28], such as a native long chain proteins or short peptide
sequences derived from intact ECM proteins, that can incur
specific interactions with cell receptors should benefit from
the description of biological characteristics of cells in the
presence of naturally derived cardiac ECM.
In summary, this study highlights the potential use
of cardiac fibroblast-derived ECM for in vitro studies of
the interactions between components of ECM and cardiac
primitive cells responsible for tissue regeneration. In the era
of tissue engineering, the choice of biomimetic materials
and natural biological components should be based on their
specific role on cardiac cell biology. Ensuing knowledge
would deepen our understanding of the biochemical cues
that regulate cardiac primitive cell survival, proliferation,
migration, and, possibly, differentiation, and, hence, guide
cardiac tissue regeneration.
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